Trials / Sponsors / James Rubenstein
James Rubenstein
Academic / Other · 3 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Tafasitamab Plus Lenalidomide in Relapsed CNS Lymphoma CNS Lymphoma, Primary Central Nervous System Lymphoma, Secondary Central Nervous System Lymphoma | Phase 1 / Phase 2 | 2022-06-08 |
| Unknown | Feasibility of Acquiring Hyperpolarized Imaging in Patients With Primary CNS Lymphoma Primary CNS Lymphoma | Phase 1 | 2021-06-29 |
| Completed | Lenalidomide Plus Rituximab for Recurrent/Refractory CNS and Intraocular Lymphoma Recurrent/Refractory CNS, Intraocular Lymphoma | Phase 1 | 2012-12-17 |